Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

This study has been terminated.
(Slow accrual)
Sponsor:
Information provided by (Responsible Party):
Seppo W. Langer, Danish Oncological Lung Cancer Group
ClinicalTrials.gov Identifier:
NCT00812266
First received: December 19, 2008
Last updated: January 23, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2015
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)